The U.S. Preventive Services Task Force (USPSTF) issued updated draft recommendations in April 2024 for breast cancer screening, now advising biennial mammograms for women aged 40 to 74. This change lowers the recommended starting age from 50 to 40, aiming to save more lives and reduce health disparities, especially for Black women, who are 40% more likely to die from breast cancer. The USPSTF's recommendation carries a B-grade, indicating high certainty of moderate net benefit or moderate certainty of substantial net benefit.
These new guidelines contrast with recommendations from other major medical organizations. The American Cancer Society (ACS) and the American College of Radiology (ACR) generally recommend annual mammograms for women at average risk starting at age 40, while the American College of Obstetricians and Gynecologists (ACOG) suggests starting between ages 40 and 49, followed by annual or biennial screening. Experts acknowledge that screening has benefits, such as early detection and reduced mortality, but also potential harms like false positives, unnecessary biopsies, and overdiagnosis.
Given the differing guidelines, medical experts emphasize the importance of shared decision-making between patients and their healthcare providers. This involves discussing individual risk factors, family history, and personal preferences to determine the most appropriate screening schedule. For women with dense breasts, supplemental screening methods like MRI or ultrasound may also be necessary in addition to mammography.
